|
30.01.2023 07:00:28
|
HBM Healthcare Investments informs about a temporary change in the Executive Board
|
HBM Healthcare Investments AG / Key word(s): Personnel Dr Andreas Wicki, Chief Executive Officer of HBM Healthcare Investments, will be taking a brief leave of absence to adress a treatable health matter. Dr Wicki will remain involved to the extent practicable. In the interim, Hans Peter Hasler, Chairman of the Board of Directors, will be responsible for the management of HBM Healthcare Investments as Executive Chairman, together with CFO Erwin Troxler. They will be actively supported by Dr Matthias Fehr and Dr Ivo Staijen, who have been leading the investment teams for private equity and public equity at the investment advisor HBM Partners for several years. The Board of Directors and the employees of HBM Healthcare Investments and HBM Partners wish Andreas Wicki a speedy recovery. Contact End of Inside Information |
| Language: | English |
| Company: | HBM Healthcare Investments AG |
| Bundesplatz 1 | |
| 6300 Zug | |
| Switzerland | |
| Phone: | +41438887171 |
| Fax: | +41438887172 |
| E-mail: | info@hbmhealthcare.com |
| Internet: | https://www.hbmhealthcare.com |
| ISIN: | CH0012627250 |
| Valor: | 1262725 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1545913 |
| End of Announcement | EQS News Service |
|
|
1545913 30-Jan-2023 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu HBM Healthcare Investments AGmehr Nachrichten
|
03.01.25 |
HBM Healthcare Investments überzeugt mit einer Wertsteigerung des NAV von 15 Prozent im Kalenderjahr 2024 (EQS Group) | |
|
03.01.25 |
HBM Healthcare Investments reports a compelling 15 percent increase in NAV in the 2024 calendar year (EQS Group) | |
|
03.01.25 |
Key Figures 31.12.2024 (EQS Group) | |
|
18.12.24 |
Successful IPO of HBM portfolio company Sai Life Sciences on the Indian stock exchanges NSE and BSE increases NAV per HBM share by 3.2 percent (EQS Group) | |
|
18.12.24 |
Erfolgreicher Börsengang des HBM-Portfoliounternehmens Sai Life Sciences an den indischen Börsen NSE und BSE erhöht NAV pro HBM-Aktie um 3.2 Prozent (EQS Group) | |
|
16.12.24 |
Key Figures 15.12.2024 (EQS Group) | |
|
02.12.24 |
Key Figures 30.11.2024 (EQS Group) | |
|
18.11.24 |
Key Figures 15.11.2024 (EQS Group) |
Analysen zu HBM Healthcare Investments AGmehr Analysen
Aktien in diesem Artikel
| HBM Healthcare Investments AG | 164,00 | 0,61% |
|
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.